Differential Proinflammatory Signature in Vestibular Migraine and Meniere Disease

Autor: Marisa Flook, Lidia Frejo, Alvaro Gallego-Martinez, Eduardo Martin-Sanz, Marcos Rossi-Izquierdo, Juan Carlos Amor-Dorado, Andres Soto-Varela, Sofia Santos-Perez, Angel Batuecas-Caletrio, Juan Manuel Espinosa-Sanchez, Patricia Pérez-Carpena, Marta Martinez-Martinez, Ismael Aran, Jose Antonio Lopez-Escamez
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
0301 basic medicine
área bajo la curva
humanos
Basal (phylogenetics)
susceptibilidad a enfermedades
0302 clinical medicine
Diagnosis
mediadores de la inflamación
differential diagnosis
Leukocytes
IL-1 beta
Immunology and Allergy
Gene Regulatory Networks
Vestibular Migraine
Age of Onset
mediana edad
Original Research
biología computacional
anciano
CCL3
enfermedad de Meniere
Area under the curve
Middle Aged
adulto
CXCL1
IL-1β
trastornos migrañosos
Area Under Curve
Cytokines
Female
Differential diagnosis
Disease Susceptibility
Symptom Assessment
Inflammation Mediators
medicine.symptom
redes génicas reguladoras
lcsh:Immunologic diseases. Allergy
Adult
leucocitos
Migraine Disorders
estudios de casos y controles
Immunology
Peripheral blood mononuclear cell
Proinflammatory cytokine
Diagnosis
Differential

03 medical and health sciences
medicine
Humans
perfiles de expresión génica
Meniere Disease
Aged
business.industry
Gene Expression Profiling
Computational Biology
medicine.disease
diagnóstico
030104 developmental biology
Migraine
Case-Control Studies
Leukocytes
Mononuclear

citocinas
evaluación de síntomas
lcsh:RC581-607
business
Biomarkers
CCL22
Tinnitus
030215 immunology
Zdroj: Digibug. Repositorio Institucional de la Universidad de Granada
Consejo Superior de Investigaciones Científicas (CSIC)
Frontiers in Immunology
Frontiers in Immunology, Vol 10 (2019)
DOI: 10.3389/fimmu.2019.01229
Popis: Vestibular Migraine (VM) and Meniere's Disease (MD) are episodic vestibular syndromes defined by a set of associated symptoms such as tinnitus, hearing loss or migraine features during the attacks. Both conditions may show symptom overlap and there is no biological marker to distinguish them. Two subgroups of MD patients have been reported, according to their IL-1 beta profile. Therefore, considering the clinical similarity between VM and MD, we aimed to investigate the cytokine profile of MD and VM as a means to distinguish these patients. We have also carried out gene expression microarrays and measured the levels of 14 cytokines and 11 chemokines in 129 MD patients, 82 VM patients, and 66 healthy controls. Gene expression profile in peripheral blood mononuclear cells (PBMC) showed significant differences in MD patients with high and low basal levels of IL-1 beta and VM patients. MD patients with high basal levels of IL- 1 beta (MDH) had overall higher levels of cytokines/chemokines when compared to the other subsets. CCL4 levels were significantly different between MDH, MD with low basal levels of IL- 1 beta (MDL), VM and controls. Logistic regression identified IL- 1 beta, CCL3, CCL22, and CXCL1 levels as capable of differentiating VM patients from MD patients (area under the curve = 0.995), suggesting a high diagnostic value in patients with symptoms overlap.
This work was supported by PI13/1242 and PI17/1644 Grant from ISCIII by FEDER Funds from the EU. Marisa Flook is funded by FI18/00228 from ISCIII.
Databáze: OpenAIRE